Home > Insider Trading > Filing (0000899243-20-008324)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1596946	Quotient Ltd	QTNT	In Vitro & In Vivo Diagnostic Substances (2835)	264719797

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1801388	Peter Buhler	C/O Quotient Limited, B1, Business Park Terre Bonne, Route De Crassier 13 Eysins V8 1262	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-03-13	10,000	$4.04	10,000	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Holdings

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Ordinary Shares	Restricted StockUnits	$0.00			50,000	50,000	Direct
Ordinary Shares	Ordinary Share Option (Right to Buy)	$7.57		2030-02-05	25,000	25,000	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
	50,000	50,000	Direct
2030-02-05	25,000	25,000	Direct

Footnotes

Restricted Stock Units convert into ordinary shares on a one-for-one basis.
On February 5, 2020, the Reporting Person was granted 50,000 Restricted Stock Units, vesting in three equal annual installments beginning February 5, 2021. The Restricted Stock Units were granted as an inducement grant pursuant to Nasdaq listing rule 5635(c)(4).
The option vests and becomes exercisable in three equal annual installments beginning February 5, 2021. The option was granted as an inducement grant pursuant to Nasdaq listing rule 5635(c)(4).